No Data
Stocks that moved and those that were traded in the front market.
* Komatsu Wall <7949> 1780 - The significant increase in the dividend plan raises the appeal of the yield. * Sumitomo Pharma <4506> 787 +100 The substantial upward revision beyond expectations has an impact. * Square Enix HD <9684> 8121 +993 3D Investment emerged as a major shareholder. * S.M.S <2175> 1360 +168 The forecast of double-digit profit growth this period and the strengthening of shareholder returns are well received. * Genky Drug Stores <9267> 3630 +42
ASTMAX: Notice regarding dividends from surplus
ASTMAX: Notice regarding the expected difference between preliminary consolidated financial results for the fiscal year ending 2025/3 and consolidated earnings for the fiscal year ending 2024/3
Astmax Sees FY Net Y146.00M
JR East reports a 18.1% increase in operating profit for the third quarter, totaling 352.5 billion yen.
The performance results for the third quarter of the fiscal year ending March 2025 announced by JR East (9020) showed a revenue of 2 trillion 126 billion 70 million yen, which is a 6.2% increase compared to the same period last year, and an operating profit of 352.5 billion 53 million yen, an 18.1% increase year-on-year. The progress rate of operating profit against the full-year plan is 95.2%. Railroad transport revenue increased by 6% to 1 trillion 334.4 billion yen, recovering to a level that is 5% lower than the same period in 2019 before the COVID-19 crisis. Travel demand has increased, and the use of stores and hotels within stations has also been strong. 【Positive Evaluation】<4
ASTMAX: Financial results briefing materials for the 3rd quarter [13th term] of the fiscal year ending 2025/3
